Lorazepam

Product NDC: 67544-870
11-digit product format: 675440870
Labeler code: 67544
Product ID: 67544-870_dc10ad3e-db44-4346-8945-fe25b0999f9f
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: lorazepam
Dosage form: TABLET
Route: ORAL
Labeler: Aphena Pharma Solutions - Tennessee, LLC
Application: ANDA077657
Marketing category: ANDA
Marketing start: 2013-03-05
Marketing end: 0000-00-00
Substance: LORAZEPAM
Active strength: 1 mg/1
Pharmacologic classes: Benzodiazepine [EPC],Benzodiazepines [CS]
DEA schedule: CIV
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 12 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	67544-870		D	Discontinued by firm	2026-08-17
excluded package	package	67544-870	67544-870-10	D	Discontinued by firm	2026-08-17
excluded package	package	67544-870	67544-870-15	D	Discontinued by firm	2026-08-17
excluded package	package	67544-870	67544-870-20	D	Discontinued by firm	2026-08-17
excluded package	package	67544-870	67544-870-30	D	Discontinued by firm	2026-08-17
excluded package	package	67544-870	67544-870-45	D	Discontinued by firm	2026-08-17
excluded package	package	67544-870	67544-870-53	D	Discontinued by firm	2026-08-17
excluded package	package	67544-870	67544-870-60	D	Discontinued by firm	2026-08-17
excluded package	package	67544-870	67544-870-70	D	Discontinued by firm	2026-08-17
excluded package	package	67544-870	67544-870-75	D	Discontinued by firm	2026-08-17
excluded package	package	67544-870	67544-870-80	D	Discontinued by firm	2026-08-17
excluded package	package	67544-870	67544-870-92	D	Discontinued by firm	2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 4 · 192 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	67544-870-10	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	67544-870-75	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	67544-870-60	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	67544-870-53	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	67544-870-80	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	67544-870-45	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	67544-870-92	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	67544-870-70	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	67544-870-15	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	67544-870-30	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	67544-870-20	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	67544-870-10	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	67544-870-75	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	67544-870-60	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	67544-870-53	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	67544-870-80	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	67544-870-45	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	67544-870-92	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	67544-870-70	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	67544-870-15	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	67544-870-30	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	67544-870-20	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	67544-870-10	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	67544-870-75	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	67544-870-60	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	67544-870-53	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	67544-870-80	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	67544-870-45	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	67544-870-92	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	67544-870-70	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	67544-870-15	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	67544-870-30	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	67544-870-20	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	67544-870-10	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	67544-870-75	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	67544-870-60	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	67544-870-53	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	67544-870-80	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	67544-870-45	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	67544-870-92	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	67544-870-70	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	67544-870-15	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	67544-870-30	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	67544-870-20	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	67544-870-10	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	67544-870-75	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	67544-870-60	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	67544-870-53	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	67544-870-80	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	67544-870-45	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	67544-870-92	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	67544-870-70	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	67544-870-15	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	67544-870-30	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	67544-870-20	`cfe11265f3b6…`	`090c488252e2…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	Approval date
A077657-001	LORAZEPAM	LORAZEPAM	0.5MG	TABLET / ORAL	2006-03-16
A077657-002	LORAZEPAM	LORAZEPAM	1MG	TABLET / ORAL	2006-03-16
A077657-003	LORAZEPAM	LORAZEPAM	2MG	TABLET / ORAL	2006-03-16

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 126 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A077657-001	LORAZEPAM	0.5MG	TABLET / ORAL	2006-03-16	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077657-002	LORAZEPAM	1MG	TABLET / ORAL	2006-03-16	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077657-003	LORAZEPAM	2MG	TABLET / ORAL	2006-03-16	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A077657-001	LORAZEPAM	0.5MG	TABLET / ORAL	2006-03-16	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077657-002	LORAZEPAM	1MG	TABLET / ORAL	2006-03-16	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077657-003	LORAZEPAM	2MG	TABLET / ORAL	2006-03-16	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077657-001	LORAZEPAM	0.5MG	TABLET / ORAL	2006-03-16	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077657-002	LORAZEPAM	1MG	TABLET / ORAL	2006-03-16	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077657-003	LORAZEPAM	2MG	TABLET / ORAL	2006-03-16	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077657-001	LORAZEPAM	0.5MG	TABLET / ORAL	2006-03-16	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077657-002	LORAZEPAM	1MG	TABLET / ORAL	2006-03-16	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077657-003	LORAZEPAM	2MG	TABLET / ORAL	2006-03-16	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077657-001	LORAZEPAM	0.5MG	TABLET / ORAL	2006-03-16	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077657-002	LORAZEPAM	1MG	TABLET / ORAL	2006-03-16	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077657-003	LORAZEPAM	2MG	TABLET / ORAL	2006-03-16	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077657-001	LORAZEPAM	0.5MG	TABLET / ORAL	2006-03-16	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077657-002	LORAZEPAM	1MG	TABLET / ORAL	2006-03-16	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077657-003	LORAZEPAM	2MG	TABLET / ORAL	2006-03-16	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077657-001	LORAZEPAM	0.5MG	TABLET / ORAL	2006-03-16	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077657-002	LORAZEPAM	1MG	TABLET / ORAL	2006-03-16	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077657-003	LORAZEPAM	2MG	TABLET / ORAL	2006-03-16	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077657-001	LORAZEPAM	0.5MG	TABLET / ORAL	2006-03-16	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077657-002	LORAZEPAM	1MG	TABLET / ORAL	2006-03-16	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077657-003	LORAZEPAM	2MG	TABLET / ORAL	2006-03-16	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077657-001	LORAZEPAM	0.5MG	TABLET / ORAL	2006-03-16	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077657-002	LORAZEPAM	1MG	TABLET / ORAL	2006-03-16	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077657-003	LORAZEPAM	2MG	TABLET / ORAL	2006-03-16	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077657-001	LORAZEPAM	0.5MG	TABLET / ORAL	2006-03-16	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077657-002	LORAZEPAM	1MG	TABLET / ORAL	2006-03-16	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077657-003	LORAZEPAM	2MG	TABLET / ORAL	2006-03-16	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A077657-001	LORAZEPAM	0.5MG	TABLET / ORAL	2006-03-16	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A077657-002	LORAZEPAM	1MG	TABLET / ORAL	2006-03-16	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A077657-003	LORAZEPAM	2MG	TABLET / ORAL	2006-03-16	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077657-001	LORAZEPAM	0.5MG	TABLET / ORAL	2006-03-16	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077657-002	LORAZEPAM	1MG	TABLET / ORAL	2006-03-16	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077657-003	LORAZEPAM	2MG	TABLET / ORAL	2006-03-16	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077657-001	LORAZEPAM	0.5MG	TABLET / ORAL	2006-03-16	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077657-002	LORAZEPAM	1MG	TABLET / ORAL	2006-03-16	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077657-003	LORAZEPAM	2MG	TABLET / ORAL	2006-03-16	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077657-001	LORAZEPAM	0.5MG	TABLET / ORAL	2006-03-16	`1e350fbaab3a…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-12-13 00:20 UTC	2019-12	A077657-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A077657-002	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A077657-003	AB	1	`74a2ff9319b5…`
2019-12-14 00:12 UTC	2019-12	A077657-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A077657-002	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A077657-003	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A077657-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A077657-002	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A077657-003	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A077657-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A077657-002	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A077657-003	AB	1	`ea99ee380514…`

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
67544-870-10	2021-12-29	22c8c913-ee81-4e96-8306-013b44ec0fd4
67544-870-15	2021-12-29	22c8c913-ee81-4e96-8306-013b44ec0fd4
67544-870-20	2021-12-29	22c8c913-ee81-4e96-8306-013b44ec0fd4
67544-870-30	2021-12-29	22c8c913-ee81-4e96-8306-013b44ec0fd4
67544-870-45	2021-12-29	22c8c913-ee81-4e96-8306-013b44ec0fd4
67544-870-53	2021-12-29	22c8c913-ee81-4e96-8306-013b44ec0fd4
67544-870-60	2021-12-29	22c8c913-ee81-4e96-8306-013b44ec0fd4
67544-870-70	2021-12-29	22c8c913-ee81-4e96-8306-013b44ec0fd4
67544-870-75	2021-12-29	22c8c913-ee81-4e96-8306-013b44ec0fd4
67544-870-80	2021-12-29	22c8c913-ee81-4e96-8306-013b44ec0fd4
67544-870-92	2021-12-29	22c8c913-ee81-4e96-8306-013b44ec0fd4
67544-870-10	2020-01-31	22c8c913-ee81-4e96-8306-013b44ec0fd4
67544-870-15	2020-01-31	22c8c913-ee81-4e96-8306-013b44ec0fd4
67544-870-20	2020-01-31	22c8c913-ee81-4e96-8306-013b44ec0fd4
67544-870-30	2020-01-31	22c8c913-ee81-4e96-8306-013b44ec0fd4
67544-870-45	2020-01-31	22c8c913-ee81-4e96-8306-013b44ec0fd4
67544-870-53	2020-01-31	22c8c913-ee81-4e96-8306-013b44ec0fd4
67544-870-60	2020-01-31	22c8c913-ee81-4e96-8306-013b44ec0fd4
67544-870-70	2020-01-31	22c8c913-ee81-4e96-8306-013b44ec0fd4
67544-870-75	2020-01-31	22c8c913-ee81-4e96-8306-013b44ec0fd4
67544-870-80	2020-01-31	22c8c913-ee81-4e96-8306-013b44ec0fd4
67544-870-92	2020-01-31	22c8c913-ee81-4e96-8306-013b44ec0fd4

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
67544-870-10	EA - Each	67544-870	3cb77870-d91f-4171-b485-49b3a2ba4e40	1	2014-05-02
67544-870-15	EA - Each	67544-870	57c1fea1-bee0-4c24-b432-2a9f6f11c895	1	2014-05-02
67544-870-20	EA - Each	67544-870	03c7be9f-3ca4-45ab-a41b-b159a5a9fbfb	1	2014-05-02
67544-870-30	EA - Each	67544-870	b76b4834-8ee7-404f-83be-0c1cb872e170	1	2014-05-02
67544-870-45	EA - Each	67544-870	f7136e2a-1644-43d8-8d76-7197e09b8abd	1	2014-05-02
67544-870-53	EA - Each	67544-870	d686c7f8-0ac8-40a1-82c8-462351de1414	1	2014-05-02
67544-870-60	EA - Each	67544-870	a9f0a696-9244-4c3b-aa90-75d807649f8f	1	2014-05-02
67544-870-70	EA - Each	67544-870	2dfeeb22-de0c-42b0-bd19-c37008bccb26	1	2014-05-02
67544-870-75	EA - Each	67544-870	e0867a42-bb9c-4844-b268-989ad3bac42a	1	2014-05-02
67544-870-80	EA - Each	67544-870	40d643dc-c5ff-4847-873c-cc6dd961203b	1	2014-05-02
67544-870-92	EA - Each	67544-870	5ff9420f-71be-4ce9-b78b-af19d592b929	1	2014-05-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
LORAZEPAM	ACTIVE INGREDIENT	O26FZP769L	LORAZEPAM TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2
LORAZEPAM	ACTIVE MOIETY	O26FZP769L	LORAZEPAM TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	LORAZEPAM TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	LORAZEPAM TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2
POLACRILIN POTASSIUM	INACTIVE INGREDIENT	0BZ5A00FQU	LORAZEPAM TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2
SODIUM STEARYL FUMARATE	INACTIVE INGREDIENT	7CV7WJK4UI	LORAZEPAM TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
O26FZP769L	LORAZEPAM	846-49-1	LORAZEPAM

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Lorazepam - Aphena Pharma Solutions - Tennessee, LLC	Aphena Pharma Solutions - Tennessee, LLC	2014-04-02	HUMAN PRESCRIPTION DRUG LABEL	2